Back to search

Article

Monotherapy efficacy of BBB-permeable small molecule activators of PP2A in glioblastoma

2019-09-23

Abstract excerpt

Glioblastoma (GB) is a fatal disease in which most targeted therapies have clinically failed. However, pharmacological reactivation of tumor suppressors has not been thoroughly studied as yet as a GB therapeutic strategy. Tumor suppressor Protein Phosphatase 2A (PP2A), is inhibited by non-genetic mechanisms in GB, and thus it would be potentially amendable for therapeutic reactivation. Here we demonstrate, that s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8817e6a-1d24-5b0b-82f6-9bd1f5168899
DOI
10.1101/777276
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Monotherapy efficacy of BBB-permeable small molecule activators of PP2A in glioblastomaDOI 10.1101/777276
Select a neighboring publication to make it the new centre.